The Pharma industry is up 1.8% in the last week, with Bora Pharmaceuticals up 12%. This takes the industry's 12 month performance to a gain of 3.9%. Earnings are forecast to grow by 39% annually.
Has the Taiwanese Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sat, 18 May 2024 | NT$635.2b | NT$102.3b | NT$9.4b | 26.6x | 67.5x | 6.2x |
Mon, 15 Apr 2024 | NT$714.5b | NT$101.5b | NT$9.2b | 26.7x | 77.5x | 7x |
Wed, 13 Mar 2024 | NT$632.3b | NT$99.9b | NT$8.9b | 24.7x | 71.1x | 6.3x |
Fri, 09 Feb 2024 | NT$597.8b | NT$101.6b | NT$8.2b | 23.4x | 73.3x | 5.9x |
Sun, 07 Jan 2024 | NT$581.2b | NT$101.9b | NT$7.8b | 24.2x | 74.6x | 5.7x |
Tue, 05 Dec 2023 | NT$594.4b | NT$101.6b | NT$7.7b | 24.7x | 77.6x | 5.8x |
Thu, 02 Nov 2023 | NT$552.9b | NT$101.6b | NT$9.7b | 22x | 57.1x | 5.4x |
Sat, 30 Sep 2023 | NT$548.8b | NT$101.7b | NT$9.6b | 22x | 57x | 5.4x |
Mon, 28 Aug 2023 | NT$535.9b | NT$101.7b | NT$9.6b | 21.9x | 55.7x | 5.3x |
Wed, 26 Jul 2023 | NT$601.2b | NT$98.7b | NT$10.1b | 16.9x | 59.7x | 6.1x |
Fri, 23 Jun 2023 | NT$578.4b | NT$98.7b | NT$10.1b | 17.1x | 57.5x | 5.9x |
Sun, 21 May 2023 | NT$576.6b | NT$93.8b | NT$9.4b | 19.3x | 61.4x | 6.1x |
Tue, 18 Apr 2023 | NT$589.5b | NT$91.6b | NT$8.6b | 22.7x | 68.8x | 6.4x |
Thu, 16 Mar 2023 | NT$545.1b | NT$85.6b | NT$6.7b | 20.3x | 81.9x | 6.4x |
Sat, 11 Feb 2023 | NT$539.9b | NT$84.6b | NT$7.9b | 23.4x | 68.5x | 6.4x |
Mon, 09 Jan 2023 | NT$487.0b | NT$84.6b | NT$7.9b | 20.3x | 61.8x | 5.8x |
Wed, 07 Dec 2022 | NT$487.5b | NT$84.6b | NT$7.9b | 16.6x | 61.8x | 5.8x |
Fri, 04 Nov 2022 | NT$409.4b | NT$79.1b | NT$4.3b | 17.2x | 94.1x | 5.2x |
Sun, 02 Oct 2022 | NT$429.6b | NT$78.9b | NT$4.3b | 17.5x | 99.3x | 5.4x |
Tue, 30 Aug 2022 | NT$468.0b | NT$78.9b | NT$4.3b | 18.5x | 108.2x | 5.9x |
Thu, 28 Jul 2022 | NT$394.0b | NT$76.7b | NT$4.4b | 21.6x | 88.7x | 5.1x |
Sat, 25 Jun 2022 | NT$398.1b | NT$76.8b | NT$4.4b | 21.6x | 91.1x | 5.2x |
Mon, 23 May 2022 | NT$375.1b | NT$76.8b | NT$4.4b | 19.7x | 85.9x | 4.9x |
Wed, 20 Apr 2022 | NT$415.0b | NT$76.5b | NT$6.5b | 22x | 63.6x | 5.4x |
Fri, 18 Mar 2022 | NT$388.6b | NT$77.1b | NT$8.1b | 20.3x | 47.9x | 5x |
Sun, 13 Feb 2022 | NT$391.0b | NT$76.7b | NT$8.5b | 19.2x | 46.2x | 5.1x |
Tue, 11 Jan 2022 | NT$384.5b | NT$76.7b | NT$8.5b | 18.4x | 45.4x | 5x |
Thu, 09 Dec 2021 | NT$392.0b | NT$76.7b | NT$8.5b | 17.1x | 46.3x | 5.1x |
Sat, 06 Nov 2021 | NT$368.5b | NT$76.0b | NT$10.5b | 17.6x | 35.2x | 4.8x |
Mon, 04 Oct 2021 | NT$353.7b | NT$76.0b | NT$10.7b | 19.5x | 32.9x | 4.7x |
Wed, 01 Sep 2021 | NT$353.3b | NT$76.0b | NT$10.7b | 20x | 32.9x | 4.6x |
Thu, 08 Jul 2021 | NT$369.1b | NT$76.0b | NT$10.7b | 19.1x | 34.4x | 4.9x |
28.3x
Which industries have driven the changes within the Taiwanese Healthcare industry?
TW Market | 2.50% | |
Healthcare | 3.94% | |
Pharma | 3.31% | |
Pharma | 3.31% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
6472 Bora Pharmaceuticals | NT$800.00 | 12.2% +NT$8.8b | 33.4% | PE26.6x | |
1795 Lotus Pharmaceutical | NT$301.00 | 4.7% +NT$3.6b | -12.4% | PE20.2x | |
4743 Oneness Biotech | NT$159.00 | 3.9% +NT$2.7b | -19.1% | PS832.5x | |
6785 Alar Pharmaceuticals | NT$280.00 | 11.1% +NT$1.9b | 64.7% | PE45.5x | |
1720 Standard Chemical & Pharmaceutical | NT$72.10 | 7.0% +NT$839.9m | 3.9% | PE14.7x |